Three small integrin-binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases

被引:55
作者
Fedarko, NS
Jain, A
Karadag, A
Fisher, LW
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr, Baltimore, MD 21224 USA
[2] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
bone sialoprotein; osteopontin; dentin matrix protein 1;
D O I
10.1096/fj.03-0966fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are critical for development, wound healing, and for the progression of cancer. It is generally accepted that MMPs are secreted in a latent form (proMMP) and are activated only upon removal of their inhibitory propeptides. This report shows that three members of the SIBLING (Small, Integrin-Binding LIgand, N-linked Glycoprotein) family can specifically bind (K(d)approximate tonM) and activate three different MMPs. Binding of SIBLING to their corresponding proMMPs is associated with structural changes as indicated by quenching of intrinsic tryptophan fluorescence, increased susceptibility to plasmin cleavage, and decreased inhibition by specific natural and synthetic inhibitors. Activation includes both making the proMMPs enzymatically active and the reactivation of the TIMP (tissue inhibitors of MMP) inhibited MMPs. Bone sialoprotein specifically binds proMMP-2 and active MMP-2, while osteopontin binds proMMP-3 and active MMP-3, and dentin matrix protein-1 binds proMMP-9 and active MMP-9. Both pro and active MMP-SIBLING complexes are disrupted by the abundant serum protein, complement Factor H, thereby probably limiting SIBLING-mediated activation to regions immediately adjacent to sites of secretion in vivo. These data suggest that the SIBLING family offers an alternative method of controlling the activity of at least three MMPs.
引用
收藏
页码:734 / +
页数:21
相关论文
共 36 条
  • [1] Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis
    Bellahcène, A
    Bonjean, K
    Fohr, B
    Fedarko, NS
    Robey, FA
    Young, MF
    Fisher, LW
    Castronovo, V
    [J]. CIRCULATION RESEARCH, 2000, 86 (08) : 885 - 891
  • [2] Bellahcene A, 1996, INT J CANCER, V69, P350
  • [3] BELLAHCENE A, 1994, CANCER RES, V54, P2823
  • [4] Expression of bone sialoprotein in human lung cancer
    Bellahcene, A
    Maloujahmoum, N
    Fisher, LW
    Pastorino, H
    Tagliabue, E
    Menard, S
    Castronovo, V
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (03) : 183 - 188
  • [5] Ectopic expression of bone sialoprotein in human thyroid cancer
    Bellahcene, A
    Albert, V
    Pollina, L
    Basolo, F
    Fisher, LW
    Castronovo, V
    [J]. THYROID, 1998, 8 (08) : 637 - 641
  • [6] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [7] EXPRESSION OF BONE SIALOPROTEIN (BSP) IN DEVELOPING HUMAN TISSUES
    BIANCO, P
    FISHER, LW
    YOUNG, MF
    TERMINE, JD
    ROBEY, PG
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1991, 49 (06) : 421 - 426
  • [8] Osteopontin expression in lung cancer
    Chambers, AF
    Wilson, SM
    Kerkvliet, N
    OMalley, FP
    Harris, JF
    Casson, AG
    [J]. LUNG CANCER, 1996, 15 (03) : 311 - 323
  • [9] Dentin matrix protein 1 is expressed in human lung cancer
    Chaplet, M
    De Leval, L
    Waltregny, D
    Detry, C
    Fornaciari, G
    Bevilacqua, G
    Fisher, LW
    Castronovo, V
    Bellahcène, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (08) : 1506 - 1512
  • [10] Fedarko NS, 2001, CLIN CANCER RES, V7, P4060